Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IACE-OS: Intra-arterial Cisplatin Plus Rh-endostatin in Osteosarcoma
NCT06562673Phase 2Completed
- Sponsor
- Shanghai Sixth People's Hospital
- Start
- Dec 2024
- Primary completion
- Apr 2025
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 2 trial of endostar in osteosarcoma (OS), sponsored by Shanghai Sixth People's Hospital. Started Dec 2024; status: completed.
02
Drugs
endostar
03
Conditions
osteosarcoma (OS)
Beyond the preview
Go deeper on NCT06562673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06562673.